CD4 Molecule: A Review of Structural Characteristics, T Cell Subsets, Signaling Pathways, Disease Associations and Progress in Targeted Drug Development

1. Introduction: The Core Position and Research Value of CD4 in the Immune System

CD4 is a key transmembrane glycoprotein in the adaptive immune system, mainly expressed on the surface of helper T cells (CD4+ T cells), monocytes, macrophages and dendritic cells. Among them, on CD4+ T cells, CD4 acts as a coreceptor for the T cell receptor (TCR), and by binding to major histocompatibility complex class II (MHC-II) molecules, it cooperatively mediates T cell activation, making it an important hub for the initiation and regulation of adaptive immune responses.

CD4+ T cells have significant functional diversity and can differentiate into multiple subsets such as Th1, Th2, Th17 and Treg, playing irreplaceable roles in immune assistance, inflammatory regulation and maintenance of immune tolerance ^[1]. In recent years, with the development of imaging technology, single-cell analysis and computational models, researchers' understanding of CD4 molecules has continued to deepen. For example, super-resolution imaging studies have revealed the nanoscale distribution of CD4 on the plasma membrane of resting T cells and its characteristics affected by palmitoylation ^[2]; tumor immune microenvironment studies have shown that automatic identification and classification of CD4+ T cells contributes to prognostic evaluation and treatment response analysis ^[3]; artificial intelligence-driven imaging analysis also shows potential in distinguishing CD4 and CD8 cells ^[4].

At the same time, drug development targeting CD4 continues to advance. Taking the humanized anti-CD4 monoclonal antibody Zanolimumab as an example, it can inhibit CD4+ T cells by inhibiting TCR signal transduction, inducing Fc-dependent effector mechanisms and down-regulating cell surface CD4 expression, and is currently used in related research on skin and lymph node T cell lymphoma ^[5]. These advances indicate that CD4 is not only a key molecule for understanding immune regulation mechanisms, but also has important disease research and drug development value.

2. Molecular Characteristics and Basic Functions of CD4

2.1 Structure and Cell Surface Expression of CD4

CD4 is usually a single-chain transmembrane glycoprotein, composed of four immunoglobulin-like extracellular domains (D1-D4), a transmembrane region and a shorter intracellular region. The extracellular D1 and D2 domains are mainly involved in binding to MHC class II molecules, while the intracellular region is closely associated with the Lck tyrosine kinase, thereby participating in the initiation and regulation of TCR signaling.

In addition to classical CD4+ T cells, CD4 is also expressed on the surface of immune cells such as macrophages, dendritic cells and monocytes, so its function is not limited to T cell activation, but is also closely related to processes such as antigen presentation, viral infection and immune microenvironment regulation. In recent years, quantitative imaging methods based on TIRF and SOFI have improved the resolution of nanoscale distribution of CD4 on the membrane surface, further confirming the importance of palmitoylation for the distribution pattern of CD4 ^[2]. In addition, artificial intelligence-assisted label-free imaging technology also suggests that CD4 has high application potential as a cell surface marker in cell recognition and classification ^[4].

2.2 Mechanism of Action of CD4 as a TCR Coreceptor

In T cell-mediated immune responses, the core role of CD4 is to assist TCR in recognizing antigen peptides presented by MHC class II molecules on the surface of antigen-presenting cells. CD4 enhances the stability of the TCR-pMHC complex by binding to MHC II, thereby improving the efficiency and specificity of T cell antigen recognition.

In addition to stabilizing the recognition complex, CD4 can also recruit and regulate the activity of p56lck through the intracellular region. Activated p56lck can phosphorylate the ITAM motif of the CD3 chain in the TCR complex, thereby initiating the early signal cascade of T cells. It is worth noting that studies on anti-CD4 antibodies suggest that CD4 is not only involved in activation, but also related to inhibitory regulation. Studies have shown that Zanolimumab can rapidly inhibit early TCR signaling and activate CD4-associated p56lck, which suggests that it may change the coupling state of p56lck and the TCR complex, and instead activate inhibitory signaling molecules such as Dok-1 and SHIP-1, thereby achieving inhibition of T cell function ^[5]. This indicates that CD4 is not just a simple coreceptor, but also an important node connecting recognition, kinase recruitment and signal regulation.

3. CD4+ T Cell Biology: Subsets, Differentiation and Regulatory Mechanisms

3.1 Functional Diversity of CD4+ T Cell Subsets

CD4+ T cells are highly heterogeneous and can differentiate into different subsets according to transcription factor expression and cytokine secretion profiles. Classical subsets include Th1, Th2, Th17 and Treg:

• Th1 cells mainly secrete IFN-γ, mediating immunity against intracellular pathogens and anti-tumor immunity ^[6]
• Th2 cells are characterized by IL-4, IL-5 and IL-13, and are mainly involved in anti-parasite immunity and allergic reactions
• Th17 cells secrete IL-17A and IL-17F, play a role in resistance to extracellular pathogen infection, but excessive activation can promote autoimmune inflammation ^[7]
• Treg cells maintain immune tolerance and inhibit excessive immune response through Foxp3, IL-10 and TGF-β ^[8]

In addition to classical Th subsets, Tfh and CD4 CTL are also important types that have received high attention in recent years:

• Tfh cells play a key role in B cell activation, antibody affinity maturation and germinal center reaction, and have shown important significance in chronic infection and chronic graft-versus-host disease ^[11-12]
• CD4 CTL breaks through the traditional concept of "helper T cells", has direct cytotoxicity mediated by perforin and granzyme, and can participate in the clearance of infected cells or tumor cells ^[1]
• In addition, some studies have also identified CD4+ T cell subsets with stem cell-like characteristics, which can continuously replenish effector cells and play a role similar to "disease stem cells" in the maintenance of chronic inflammation ^[14]

3.2 Regulation of CD4+ T Cell Differentiation and Plasticity

The differentiation of CD4+ T cells is jointly regulated by antigen strength, cytokine environment and transcription factor network:

• Antigen affinity and dose are important early signals that determine the fate of naive T cells ^[15]
• The type, concentration and ratio of exogenous and endogenous cytokines determine whether differentiation presents a突变 or gradual change ^[16]
• For example, IL-2 can regulate Foxp3 expression, thereby affecting the formation of induced Treg ^[17]

At the intracellular regulatory level, transcription factors such as Bcl6, Maf, ThPOK, Runx3, and Eomes are involved in shaping the fate and function of different CD4+ T cell subsets ^[13],^[18-19]. These factors antagonize or cooperate with each other, enabling CD4+ T cells to dynamically remodel according to different microenvironments such as infection, inflammation or tumor, thereby reflecting strong plasticity. This plasticity is the basis for the flexibility of immune response, and also increases the complexity of disease research and therapeutic intervention.

3.3 Proliferation, Survival and Metabolic Reprogramming of CD4+ T Cells

After activation, CD4+ T cells need to undergo rapid proliferation and meet effector functional requirements through metabolic reprogramming. Their proliferation and survival are supported by cytokines such as IL-7, and are also regulated by metabolic pathways, mitochondrial status and intracellular energy balance ^[27]. Different subsets have differences in metabolic patterns. For example, inflammatory effector T cells usually prefer glycolysis, while regulatory T cells rely more on oxidative metabolism. Metabolic state not only affects cell survival, but also determines their differentiation direction and functional output. Therefore, metabolic regulation has become an important entry point for understanding the homeostasis and disease association of CD4+ T cells.

4. Key Signaling Pathways Regulating CD4+ T Cell Function

4.1 TCR Proximal Signaling and Calcineurin-NFAT Pathway

TCR proximal signaling is the starting point of CD4+ T cell activation. CD4 assists MHC II recognition and recruits Lck, promotes ITAM phosphorylation of the CD3 chain, and then activates downstream signaling molecules such as ZAP-70. Subsequently, calcium signal and calcineurin-NFAT pathway are activated, driving effector gene expression and regulating T cell differentiation and functional output. This pathway has a fundamental role in the early fate determination of T cells.

4.2 JAK/STAT Signaling Pathway

The JAK/STAT pathway is one of the core pathways for cytokine to regulate CD4+ T cell differentiation. Different cytokines can promote the formation of Th1, Th17 or Treg subsets by activating different STAT members. Studies have shown that some natural products or immunomodulatory factors can change the balance between Th1/Th17 and Treg by inhibiting the activity of STAT1, STAT3 or STAT5, thereby exerting therapeutic potential in inflammatory and autoimmune diseases ^[9-10].

4.3 TGF-β/SMAD and Notch Signaling Pathways

The TGF-β/SMAD pathway has an important position in Treg formation, immune tolerance maintenance and inflammatory regulation; Notch signaling plays an auxiliary regulatory role in T cell development, differentiation and functional shaping. These two pathways do not exist in isolation, but interact with pathways such as JAK/STAT to jointly participate in the fate regulation of CD4+ T cells.

4.4 cGAS/STING Pathway and Immune Metabolism Association

The cGAS/STING pathway was originally mainly considered to be involved in cytosolic DNA sensing and innate immune activation, but recent studies suggest that this pathway also affects the tumor immune microenvironment and T cell functional status. Events such as metabolic stress and mitochondrial DNA release can activate this pathway, thereby inducing type I interferon response and affecting the composition of tumor-infiltrating immune cells and the function of CD4+ T cells ^[29].

4.5 cAMP and Other Related Pathways

cAMP signaling also has important significance in the immune regulation of CD4+ T cells. Relevant studies have shown that cAMP pathway activators such as Forskolin can regulate the CD4+ T cell response in autoimmune inflammation, and are associated with the remission of central nervous system inflammation ^[32]. In addition, there is extensive crosstalk between multiple signaling pathways, which together determine the functional state of CD4+ T cells under different disease backgrounds ^[28].

5. The Role of CD4+ T Cells in the Occurrence and Development of Diseases

5.1 HIV/AIDS Pathogenesis

HIV infection most typically reflects the core position of CD4 in diseases. CD4 is not only an important indicator for immune function evaluation, but also an important related molecule for HIV to invade host cells. The decrease in the number of CD4+ T cells directly reflects the degree of immune system damage, and factors such as viral load, host individual differences and immune reconstitution ability jointly determine the speed of disease progression. Therefore, CD4 count has long been an important parameter for HIV infection management and efficacy evaluation.

5.2 Autoimmune Diseases and Inflammation

In diseases such as rheumatoid arthritis, systemic lupus erythematosus, and experimental autoimmune encephalomyelitis, the imbalance of CD4+ T cell subsets is one of the key pathological mechanisms. In particular, the imbalance of Th17/Treg is often associated with chronic inflammation amplification and tissue damage ^[9-10]. A variety of metabolic interventions, cell therapies and signaling pathway regulation strategies have shown potential in alleviating diseases by remodeling CD4+ T cell function ^[26],^[30].

5.3 Cancer Immunity and Immunotherapy

In tumor immunity, CD4+ T cells can assist CD8+ T cells to exert killing effect, and can also independently mediate anti-tumor immunity, and even act as a prognostic predictive biomarker. This indicates that CD4+ T cells are not only "helpers" in tumor immunity, but may also be key "executors" under certain conditions.

5.4 Other Infectious Diseases

In addition to HIV, CD4+ T cells also play an important role in acute and chronic infections such as influenza. Especially the discovery of CD4 CTL suggests that CD4+ T cells are not only responsible for regulation in the antiviral process, but can also directly participate in the clearance of infected cells ^[1]. This expands the understanding of the functional boundary of CD4+ T cells in infection immunity.